Icon (ICLR) Non-Current Assets (2009 - 2026)
Icon's (ICLR) quarterly Non-Current Assets came in at $12.7 billion in Q2 2026, down 4.82% year-over-year from $13.3 billion in Q2 2025, and little changed quarter-over-quarter from $12.7 billion in Q1 2026.
Analysis
Icon (ICLR) Non-Current Assets (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Non-Current Assets for 18 consecutive years, with $12.7 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 4.82% year-over-year to $12.7 billion in Q2 2026; TTM through Jun 2026 was $51.8 billion, a 3.08% decrease from a year earlier, with the FY2025 full-year figure at $12.8 billion, down 4.37% from the prior year.
- Non-Current Assets was $12.7 billion for Q2 2026 at Icon, roughly flat from $12.7 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $62.7 billion in Q1 2024 and troughed at $12.7 billion in Q2 2026.
- A 5-year average of $16.4 billion and a median of $13.5 billion in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets jumped 5941.73% in 2022 and tumbled 78.78% in 2025, its largest moves.
- Over 5 years, Non-Current Assets stood at $14.0 billion in 2022, then climbed by 21.25% to $17.0 billion in 2023, then fell by 21.02% to $13.4 billion in 2024, then decreased by 4.37% to $12.8 billion in 2025, then fell by 1.4% to $12.7 billion in 2026.
- The last three Non-Current Assets figures came in at $12.7 billion (Q2 2026), $12.7 billion (Q1 2026), and $12.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 23.66 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.01 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 12.65 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 6.00 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 1.79 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 982.30 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 657.51 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 14.00 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 3.66 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.65 Bn |
| Mar 31, 2026 | 12.71 Bn |
| Dec 31, 2025 | 12.83 Bn |
| Sep 30, 2025 | 13.10 Bn |
| Jun 30, 2025 | 13.29 Bn |
| Mar 31, 2025 | 13.31 Bn |
| Dec 31, 2024 | 13.42 Bn |
| Sep 30, 2024 | 13.43 Bn |
| Jun 30, 2024 | 13.37 Bn |
| Mar 31, 2024 | 62.72 Bn |
| Dec 31, 2023 | 16.99 Bn |
| Sep 30, 2023 | 13.61 Bn |
| Jun 30, 2023 | 13.74 Bn |
| Mar 31, 2023 | 13.86 Bn |
| Dec 31, 2022 | 14.01 Bn |
| Sep 30, 2022 | 13.95 Bn |
| Jun 30, 2022 | 14.11 Bn |
| Mar 31, 2022 | 14.29 Bn |
| Dec 31, 2021 | 14.53 Bn |
| Sep 30, 2021 | 14.52 Bn |